| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/28/2005 | EP1578449A2 Compositions of benzoquinolizine carboxylic acid antibiotic drugs |
| 09/28/2005 | EP1578421A2 Pharmaceutical preparations for treatments of diseases and disorders of the breast |
| 09/28/2005 | EP1578403A2 Modified release compositions of milnacipran |
| 09/28/2005 | EP1578402A2 Conjugates comprising an nsaid and a sugar and uses thereof |
| 09/28/2005 | EP1578398A2 Stable, non-aqueous, single-phase gels and formulations thereof for delivery from an implantable device |
| 09/28/2005 | EP1578371A2 Compositions and methods for the diagnosis and treatment of tumor |
| 09/28/2005 | EP1578355A2 Improved compositions of pegylated soluble tumor necrosis factor receptors and methods of preparing |
| 09/28/2005 | EP1578348A2 Formulation comprising bioactive agents and method of using same |
| 09/28/2005 | EP1578347A2 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 09/28/2005 | EP1578345A2 Peptides and antibodies to muc 1 proteins |
| 09/28/2005 | EP1578325A2 Stable topical drug delivery compositions |
| 09/28/2005 | EP1578253A2 Prevention and treatment of synucleinopathic disease |
| 09/28/2005 | EP1578193A2 Method for freeze-drying nucleic acid/block copolymer/cationic surfactant complexes |
| 09/28/2005 | EP1523287A4 Materials with both bioadhesive and biodegradable components |
| 09/28/2005 | EP1439846A4 Storage-stable human fibrinogen solutions |
| 09/28/2005 | EP1399034B1 Taste modifiers comprising a chlorogenic acid |
| 09/28/2005 | EP1399032B1 Improved hard sugar coating method |
| 09/28/2005 | EP1320357A4 Topical polymeric antimicrobial emulsion |
| 09/28/2005 | EP1228072B1 Pdgf receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same |
| 09/28/2005 | EP1178781B1 Multilayer pharmaceutical product for release in the colon |
| 09/28/2005 | EP1086141B1 Aloe pectins |
| 09/28/2005 | CN1675281A Biodegradable phase separated segmented multi block co-polymers |
| 09/28/2005 | CN1675245A Monoclonal antibody hPAM4 |
| 09/28/2005 | CN1675243A 结合分子 Binding molecules |
| 09/28/2005 | CN1675241A Immunogenic conjugates |
| 09/28/2005 | CN1675232A Derivatives of monosaccharides for drug discovery |
| 09/28/2005 | CN1675212A 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
| 09/28/2005 | CN1674941A Solid nano-medicine and preparing method thereof |
| 09/28/2005 | CN1674940A Topical anhydrous and ethanol-free ascomycin compositions |
| 09/28/2005 | CN1674923A Non-polymeric hematopoeitic cell clots for delivery of active agents |
| 09/28/2005 | CN1674922A Methods of treating angiogenesis, tumor growth, and metastasis |
| 09/28/2005 | CN1674920A Process for preparing a sterile high molecular weight hyaluronic acid formulation |
| 09/28/2005 | CN1674916A The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis |
| 09/28/2005 | CN1674915A A method of treating human skin and a skin care composition for use in such a method |
| 09/28/2005 | CN1674914A Female hormone-containing patch |
| 09/28/2005 | CN1674912A Methods of treatment of male erectile dysfunction |
| 09/28/2005 | CN1674903A Composition for transnasal absorption |
| 09/28/2005 | CN1674896A Pharmaceutical compositions comprising FK506 derivatives and the ir use for the treatment of allergic diseases |
| 09/28/2005 | CN1674891A Porphyrin oxygen infusion preparation for increasing oxygen concentration in tumor tissue |
| 09/28/2005 | CN1674882A Aripiprazole complex formulation and method |
| 09/28/2005 | CN1674878A Immunomodulatory compositions, methods of making, and methods of use thereof |
| 09/28/2005 | CN1674876A Film coating for tablets and caplets |
| 09/28/2005 | CN1674872A Crystalline drug particles prepared using a controlled precipitation (recrystallization) process |
| 09/28/2005 | CN1674870A Liposomes containing biologically active compounds |
| 09/28/2005 | CN1674868A Ophtalmic ointment composition comprising a drug, an ointment base and a solubling/dispersing agent |
| 09/28/2005 | CN1674867A Antigenic compositions |
| 09/28/2005 | CN1674866A New sexual-dysfunction-compound-containing rapid-onset pharmaceutical formulations comprising cocoa powder and use thereof |
| 09/28/2005 | CN1674859A Use of diketopiperazine derivatives as photostable UV-filters in cosmetic and pharmaceutical preparations |
| 09/28/2005 | CN1674854A A capsule filling machine |
| 09/28/2005 | CN1672745A Local vascular delivery of etoposide in combination with rapamycin to prevent restenosis following vascular injury |
| 09/28/2005 | CN1672677A Grafted nano carbon and its suspension preparing process and medical use |
| 09/28/2005 | CN1220717C Positively charged amphiphilic block copolymer as drug carrier and complex thereof with negatively charged drug |
| 09/28/2005 | CN1220521C Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 09/28/2005 | CN1220488C Combination of fenofibrate and coenzyme Q10 for the treatment of endothelial dysfunction |
| 09/28/2005 | CN1220485C Method for making coated granules with masked taste and instant release of active matter |
| 09/28/2005 | CN1220484C Microparticles for pulmonary administation |
| 09/27/2005 | US6949620 Polymeric micellar structure |
| 09/27/2005 | US6949584 use in inhibiting angiogenesis in a mammal |
| 09/27/2005 | US6949526 Erectile dysfunction remedies containing prostaglandin derivatives as the active ingredient |
| 09/27/2005 | US6949521 Therapeutic azide compounds |
| 09/27/2005 | US6949515 Amino acid side chain-modified substrates of the enzyme; obtaining locally limited inhibition; treating inflammation, psoriasis, periodontitis, allergies, arthritis, tumors or autoimmune diseases |
| 09/27/2005 | US6949509 Pharmaceutical composition containing a small or medium size peptide |
| 09/27/2005 | US6949257 Substance P antagonist; antidepressants; central nervous system disorders; respiratory system disorders |
| 09/27/2005 | US6949256 A film-forming composition comprising carrageenan, a bulking agent, plasticizer and water; encapsulating medicinal dosage forms, nutritional supplements, cosmetics, bath oils and gels, and paint balls |
| 09/27/2005 | US6949251 Porous β-tricalcium phosphate granules for regeneration of bone tissue |
| 09/27/2005 | US6949249 Mixture contains flow control agent and thickener |
| 09/27/2005 | US6949245 Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies |
| 09/27/2005 | US6949241 Use of lacrophyl preparation in eye drops containing therapeutically active compounds |
| 09/27/2005 | US6949218 Use of low molecular weight amino alcohols in ophthalmic compositions |
| 09/27/2005 | CA2414271C Sustained-release preparations of quinolone antibiotics and method for preparation thereof |
| 09/27/2005 | CA2164109C Molecular transdermal transport system |
| 09/27/2005 | CA2079814C Cationic lipids for intracellular delivery of biologically active molecules |
| 09/26/2005 | CA2847142A1 Multiple-variable dose regimen for treating tnf.alpha.-related disorders |
| 09/22/2005 | WO2005087951A2 Reagents, methods and kits for use in deactivating nucleic acids |
| 09/22/2005 | WO2005087804A1 Erythropoietin liquid formulation |
| 09/22/2005 | WO2005087801A1 Peptide carrier for drug delivery |
| 09/22/2005 | WO2005087795A1 Use of peptides as penetrating cell carriers |
| 09/22/2005 | WO2005087271A1 Compositions comprising cells and magnetic materials for targeted delivery |
| 09/22/2005 | WO2005087257A1 Remedy for repairing cartilage tissue having crosslinked gelatin gel as support |
| 09/22/2005 | WO2005087237A1 Fasudil-containing preparation and method of improving stability thereof |
| 09/22/2005 | WO2005087230A1 Solid pharmaceutical preparation containing sparingly water-soluble drug |
| 09/22/2005 | WO2005087224A1 Composition for stabilizing epigallocatechin gallate (egcg) in water phase and preparation method thereof |
| 09/22/2005 | WO2005087221A1 Biodegradable biocompatible implant and method of manufacturing same |
| 09/22/2005 | WO2005087205A1 Process for producing medicine |
| 09/22/2005 | WO2005087202A1 Glucosamine polyacrylate inter-polymer complex and processes for their production |
| 09/22/2005 | WO2005087199A2 Stabilised supersaturated solid solutions of steroidal drugs |
| 09/22/2005 | WO2005087196A1 Drug delivery system based on immune response system |
| 09/22/2005 | WO2005087195A2 Novel compositions for topical delivery |
| 09/22/2005 | WO2005087182A1 Functional powders |
| 09/22/2005 | WO2005087016A1 Method of preparing a protein aggregate and a pharmaceutical composition |
| 09/22/2005 | WO2005086775A2 Lumen-exposed molecules and methods for targeted delivery |
| 09/22/2005 | WO2005086763A2 Stable injectable compositions |
| 09/22/2005 | WO2005086641A2 Anti-infectious hydrogel compositions |
| 09/22/2005 | WO2005086612A2 Fluorinated carbohydrate conjugates |
| 09/22/2005 | WO2005072736A3 Stable gabapentin compositions |
| 09/22/2005 | WO2005068498A3 Human therapeutic cells secreting nerve growth factor |
| 09/22/2005 | WO2005063195A3 Compositions comprising vitamins and/or derivatives thereof stabilised with olea europea extract and/or ionene polymers |
| 09/22/2005 | WO2005007069A3 Soft gel formulations for saquinavir |
| 09/22/2005 | WO2004112566A3 Diagnosis and treatment of nephropathy |
| 09/22/2005 | WO2004105686A3 Novel topical steroid cream formulations |